![]() |
Why does Monsanto (MON - commentary - Cramer's Take) elude people? Why do people not understand that we have a policy in this country and that policy makes Monsanto the Schlumberger (SLB - commentary - Cramer's Take) of its group? Why can't people grasp that there is a worldwide food shortage and Monsanto is the answer for that, too?
Every time one of these stocks reports, you get an amazing reaction: Agrium (AGU - commentary - Cramer's Take), Mosiac (MOS - commentary - Cramer's Take), Deere (DE - commentary - Cramer's Take), Syngenta (SYT - commentary - Cramer's Take) and Bunge (BG - commentary - Cramer's Take) go up. Every time. It is amazing to me that there is this kind of "you have to be kidding, this can't be that good" impact. I think some of this is a legacy from people thinking that Monsanto is a chemical stock, like a Dow (DOW - commentary - Cramer's Take) or a DuPont (DD - commentary - Cramer's Take). This is more of a biotech stock than a chemical stock. The reaction to this company's earnings report today shows me that there is just still a lack of recognition of the ag bull market and a sense that the commodity prices for food have peaked. Just the opposite. That's what this rally in ag, the endless rally, is about. Random musings: One of the reasons I dislike this market so much is that a CVS (CVS - commentary - Cramer's Take) can have a weak month at its drug stores, raise the lower end of its guidance anyway -- because of Caremark, which is Medco (MHS - commentary - Cramer's Take) and Express Scripts (ESRX - commentary - Cramer's Take) and not just drug stores -- and then just be annihilated. This stock is down a gigantic amount. I own it for Action Alerts PLUS and I am itching to buy it, as I told readers earlier this morning, when it goes below my $36 cost basis, which, at this velocity I believe will definitely happen. The ability to post comments on RealMoney blogs is disabled because of a technical problem. We're working to remedy the situation.
At the time of publication, Cramer was long CVS Caremark. Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here. TheStreet.com has a revenue-sharing relationship with Amazon.com under which it receives a portion of the revenue from Amazon.com purchases by customers directed there from TheStreet.com. Brokerage Partners
|
|||||||||||||||||||||||||||||||||||||||||